Waterfront Wealth Inc. Takes Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Waterfront Wealth Inc. acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, HoldingsChannel.com reports. The fund acquired 3,004 shares of the exchange traded fund’s stock, valued at approximately $268,000.

Other institutional investors also recently added to or reduced their stakes in the company. Resources Management Corp CT ADV boosted its holdings in shares of SPDR S&P Biotech ETF by 1,715.8% during the second quarter. Resources Management Corp CT ADV now owns 345 shares of the exchange traded fund’s stock worth $29,000 after purchasing an additional 326 shares during the period. Tyler Stone Wealth Management bought a new position in SPDR S&P Biotech ETF in the 2nd quarter worth $33,000. EPG Wealth Management LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 152.7% during the third quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock worth $34,000 after buying an additional 278 shares during the last quarter. Compass Wealth Management LLC acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $34,000. Finally, Fortis Capital Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $38,000.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI traded down $0.20 during trading on Thursday, hitting $84.45. 2,606,959 shares of the stock were exchanged, compared to its average volume of 11,583,348. SPDR S&P Biotech ETF has a 1-year low of $63.80 and a 1-year high of $103.52. The company’s fifty day simple moving average is $93.79 and its 200-day simple moving average is $84.13. The company has a market capitalization of $6.56 billion, a price-to-earnings ratio of 11.47 and a beta of 1.08.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.